Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Cancer Nurs. 2020 Jan-Feb;43(1):22–31. doi: 10.1097/NCC.0000000000000670

Table 1.

Symptom Prevalence and Mean Number of Days at Moderate to Severe Levels

Symptom Cycle No. (%) of
Women
Reported
Symptom
Severity
Greater
than 0 at
Least Once		 Mean no. Days
(SD), Range of
Symptom
Reported with
Severity Greater
than 0		 No. (%) of
Women
Reported
Symptom
Severity
Greater
than 3 at
Least Once		 Mean no. Days
(SD), Range of
Symptom
Reported with
Severity Greater
than 3		 No. Days
(%)
Symptom
Reported
Level 0		 No. Days
(%)
Symptom
Reported
Level 1–10		 No. Days
(%)
Symptom
Reported
Level 4–10
Depressed Mood a 2 99 (60.0%) 3.60 (3.21), 1–13 70 (42.4%) 3.23 (2.84), 1–12 1455 (80.3%) 356 (19.7%) 226 (12.5%)
3 83 (53.2%) 3.47 (3.11), 1–14 55 (35.3%) 2.87 (2.86), 1–13 1416 (83.1%) 288 (16.9%) 158 (9.3%)
Anxiety a 2 77 (46.7%) 3.34 (3.17), 1–13 47 (28.5%) 2.91 (2.83), 1–11 1544 (85.3%) 267 (14.7%) 147 (8.2%)
3 62 (39.7%) 3.56 (3.62), 1–13 40 (25.6%) 2.65 (2.56), 1–9 1483 (87.0%) 221 (13.0%) 106 (6.2%)
a

n=165, cycle 2; n=156, cycle 3; 1811(78.4%) days reported cycle 2, 1704(78.0%) days reported cycle 3; 499(21.6%) days missing cycle 2, 480(22.0%) days missing cycle 3